TITLE

Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes

AUTHOR(S)
Louapre, Céline; Lubetzki, Catherine
PUB. DATE
November 2015
SOURCE
Multiple Sclerosis Journal;Nov2015, Vol. 21 Issue 13, p1626
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses debates about the causes of neurodegeneration in multiple sclerosis (MS), a type of central nervous system (CNS) inflammatory disease. Topics discussed include how inflammation and neurodegeneration interplay over the disease course, the potential factors that influence neurodegeneration, and the central role that neurodegeneration play in MS pathogenesis.
ACCESSION #
110716762

 

Related Articles

  • Neuroprotection in Multiple Sclerosis: A Therapeutic Approach. Maghzi, Amir-Hadi; Minagar, Alireza; Waubant, Emmanuelle // CNS Drugs;2013, Vol. 27 Issue 10, p799 

    Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that is pathologically characterized by inflammatory demyelination and neurodegeneration. Axonal damage, along with neuronal loss, occurs from disease onset and may lead to progressive and permanent disability. In...

  • Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis. Lepore, Stefano; Waiczies, Helmar; Hentschel, Jan; Ji, Yiyi; Skodowski, Julia; Pohlmann, Andreas; Millward, Jason M.; Paul, Friedemann; Wuerfel, Jens; Niendorf, Thoralf; Waiczies, Sonia // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminated encephalomyelitis involve an invasion of immune cells that ultimately leads to white matter demyelination, neurodegeneration and development of neurological symptoms. A clinical diagnosis is...

  • Disease Modifying Therapy in Multiple Sclerosis. Williams, U. E.; Oparah, S. K.; Philip-Ephraim, E. E. // ISRN Otolaryngology;2014, p1 

    Multiple sclerosis is an autoimmune disease of the central nervous system characterized by inflammatory demyelination and axonal degeneration. It is the commonest cause of permanent disability in young adults. Environmental and genetic factors have been suggested in its etiology. Currently...

  • MRI aspects of the “inflammatory phase” of multiple sclerosis. Filippi, M.; Rocca, M. A. // Neurological Sciences;Dec2003 Supplement 5, Vol. 24, ps275 

    In early relapsing-remitting (RR) multiple sclerosis (MS), conventional magnetic resonance imaging (MRI) has proved to be a valuable tool to assess disease activity over time. However, conventional MRI can only provide gross estimates of irreversible tissue damage within and outside such...

  • Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. PARISH, CHRISTOPHER R; HINDMARSH, ELIZABETH J; BARTLETT, MARK R; STAYKOVA, MARIA A; COWDEN, WILLIAM B; WILLENBORG, DAVID O; Parish, Chris // Immunology & Cell Biology;Feb1998, Vol. 76 Issue 1, p104 

    Currently available anti-inflammatory drugs for the treatment of multiple sclerosis (MS) and other inflammatory diseases are generally inadequate, with disease progression not being arrested by the treatments and undesirable side effects posing problems. In response to these deficiencies our...

  • Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Pomeroy, I. M.; Jordan, E. K.; Frank, J. A.; Matthews, P. M.; Esiri, M. M. // Multiple Sclerosis (13524585);May2010, Vol. 16 Issue 5, p537 

    Background: Degenerative features, such as neuronal, glial, synaptic and axonal loss, have been identified in neocortical and other grey matter structures in patients with multiple sclerosis, but mechanisms for neurodegeneration are unclear. Cortical demyelinating lesions are a potential cause...

  • Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men. Kremer, David; Hartung, Hans-Peter; Küry, Patrick // Multiple Sclerosis Journal;Nov2015, Vol. 21 Issue 13, p1616 

    The authors reflect on a translational study of targeting semaphorins in multiple sclerosis (MS) treatment to improve remyelination. Topics discussed include the role of Sema7A inhibitory molecules in neuroinflammation, the expression of receptors in MS lesions, and potential targets of central...

  • Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brucklacher-Waldert, Verena; Sturner, Klarissa; Kolster, Manuela; Wolthausen, Julia; Tolosa, Eva // Brain: A Journal of Neurology;Dec2009, Vol. 132 Issue 12, p3329 

    Multiple sclerosis is a T cell-mediated demyelinating disease of the central nervous system. Interleukin-17-producing T helper cells, named Th17 cells, represent a novel CD4+ T cell effector subset involved in the response against extracellular pathogens. In addition, Th17 cells are pathogenic...

  • Elevated CNS inflammation in patients with preclinical Alzheimer's disease. Monson, Nancy L; Ireland, Sara J; Ligocki, Ann J; Chen, Ding; Rounds, William H; Li, Min; Huebinger, Ryan M; Munro Cullum, C; Greenberg, Benjamin M; Stowe, Ann M; Zhang, Rong // Journal of Cerebral Blood Flow & Metabolism;Jan2014, Vol. 34 Issue 1, p30 

    Alzheimer's disease (AD) is a progressive, neurodegenerative disease that may involve inflammatory responses in the central nervous system (CNS). Our objective was to determine whether patients with amnestic mild cognitive impairment (aMCI), a preclinical stage of AD, have inflammatory...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics